Influenza A virus H5N1 vaccine - Sinovac Biotech
Alternative Names: Pandemic influenza H5N1 whole viron inactivated vaccine - Sinovac Biotech; Panflu; Panflu (H5N1)Latest Information Update: 06 Aug 2021
At a glance
- Originator Sinovac Biotech
- Class Influenza A virus H5N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza A virus H5N1 subtype
Most Recent Events
- 19 Mar 2015 The vaccine is approved in Hong Kong
- 13 Oct 2009 Registered for prevention of Influenza-A virus H5N1 subtype in Hong Kong (IM)
- 29 Jun 2009 Registered for Influenza-A virus H5N1 subtype (whole virion) in China (IM) - First Global Approval